- Home
- DFIN vs OPK Comparison
DFIN vs OPK Comparison
Compare DFIN & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFIN
- OPK
- Stock Information
- Founded
- DFIN 1983
- OPK 2007
- Country
- DFIN United States
- OPK United States
- Employees
- DFIN N/A
- OPK N/A
- Industry
- DFIN Other Consumer Services
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- DFIN Consumer Discretionary
- OPK Health Care
- Exchange
- DFIN Nasdaq
- OPK Nasdaq
- Market Cap
- DFIN 1.2B
- OPK 998.0M
- IPO Year
- DFIN N/A
- OPK 1995
- Fundamental
- Price
- DFIN $49.20
- OPK $1.36
- Analyst Decision
- DFIN Strong Buy
- OPK Buy
- Analyst Count
- DFIN 2
- OPK 5
- Target Price
- DFIN $63.50
- OPK $2.28
- AVG Volume (30 Days)
- DFIN 293.5K
- OPK 2.9M
- Earning Date
- DFIN 10-29-2025
- OPK 10-29-2025
- Dividend Yield
- DFIN N/A
- OPK N/A
- EPS Growth
- DFIN N/A
- OPK N/A
- EPS
- DFIN 1.12
- OPK N/A
- Revenue
- DFIN $750,800,000.00
- OPK $642,067,000.00
- Revenue This Year
- DFIN N/A
- OPK N/A
- Revenue Next Year
- DFIN $4.20
- OPK N/A
- P/E Ratio
- DFIN $43.31
- OPK N/A
- Revenue Growth
- DFIN N/A
- OPK N/A
- 52 Week Low
- DFIN $37.80
- OPK $1.11
- 52 Week High
- DFIN $69.93
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- DFIN 56.28
- OPK 48.23
- Support Level
- DFIN $44.26
- OPK $1.24
- Resistance Level
- DFIN $47.40
- OPK $1.35
- Average True Range (ATR)
- DFIN 1.23
- OPK 0.06
- MACD
- DFIN 0.61
- OPK 0.01
- Stochastic Oscillator
- DFIN 99.21
- OPK 80.00
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.